U.S. Markets closed

HTG Molecular Diagnostics, Inc. (HTGM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.09+0.12 (+2.41%)
At close: 4:00PM EST

5.10 +0.01 (0.19%)
After hours: 4:46PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.97
Bid5.06 x 1000
Ask5.09 x 1100
Day's Range4.87 - 5.20
52 Week Range3.78 - 13.80
Avg. Volume190,342
Market Cap24.125M
Beta (5Y Monthly)1.68
PE Ratio (TTM)N/A
EPS (TTM)-4.72
Earnings DateNov 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.75
  • Is HTG Molecular Diagnostics, Inc. (HTGM) A Good Stock To Buy?
    Insider Monkey

    Is HTG Molecular Diagnostics, Inc. (HTGM) A Good Stock To Buy?

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

  • HTG Announces One-for-Fifteen Reverse Stock Split

    HTG Announces One-for-Fifteen Reverse Stock Split

    TUCSON, Ariz., Nov. 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that as a result of its one-for-fifteen reverse stock split which became effective at 5:00 p.m. Eastern Time on November 20, 2020, its common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market (“Nasdaq”) effective with the open of the market today, Monday, November 23, 2020. HTG’s common stock will continue to trade under the ticker symbol “HTGM.” As a result of the reverse stock split, each fifteen pre-split shares of common stock outstanding were automatically combined and converted into one issued and outstanding share of common stock. No fractional shares of common stock were issued to any stockholders in connection with the reverse stock split. Holders of record will receive a cash payment in lieu of fractional shares.  Stockholders of record will receive information regarding their share ownership from HTG’s transfer agent, American Stock Transfer & Trust Company, LLC (“AST”). AST can be reached at (877) 248-6417 or (718) 921-8337. For additional information regarding the reverse stock split, please refer to HTG’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on November 19, 2020.About HTG: HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.Contact: Ashley R. Robinson LifeSci Advisors, LLC Phone: (617) 430-7577 Email: arr@lifesciadvisors.com

  • Newsflash: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Have Been Trimming Their Revenue Forecasts
    Simply Wall St.

    Newsflash: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Have Been Trimming Their Revenue Forecasts

    The latest analyst coverage could presage a bad day for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), with the...